MELISSA SICURELLA: Open Payments
NPI 1356060685 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 54 payments from 15 companies in 2025. Trend: 2023 $1,546 · 2024 $1,763 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $188 |
| Janssen Biotech, Inc. | 5 | $156 |
| GENZYME CORPORATION | 4 | $137 |
| Galderma Laboratories, L.P. | 6 | $115 |
| Regeneron Healthcare Solutions, Inc. | 3 | $105 |
| PFIZER INC. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Incyte Corporation | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $62 |
| Lilly USA, LLC | 3 | $55 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, CIBINQO, RINVOQ, OPZELURA, Winlevi.
Industry payments across NY — which companies pay providers there.
